ACHV
$5.12
Achieve Life Sciences
($.02)
(.39%)
ACHV
Earnings Whisper ®
N/A
3rd Quarter September 2022
Consensus:  ($1.10)
Revenue:  N/A
Thursday
Nov 10
4:05 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when ACHV reports earnings?
Beat
Meet
Miss

Where is ACHV's stock price going from here?
Up
Flat
Down
Stock chart of ACHV
Analysts
Summary of analysts' recommendations for ACHV
Score
Grade
Pivots
Resistance
-
-
-

-

Support
-
-
-
Tweet
Growth
Description
Achieve Life Sciences Inc. is a pharmaceutical company. It develops and commercializes cytisine treatment to help people battling nicotine addiction. The Company's product candidates include Custirsen, Apatorsen and OGX-225. Achieve Life Sciences Inc., formerly known as OncoGenex Pharmaceuticals Inc., is based in Bothell, United States.